Brief communication (Original). Long-term aripiprazole effectiveness in bipolar disorder patients decreases with pharmacotherapeutic complexity and degree of baseline mood disturbance

1. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007; 64:543-52.10.1001/archpsyc.64.5.543193156617485606Open DOISearch in Google Scholar

2. World Health Organization. The World Health Report 2001 - Mental Health: New Understanding, New Hope. Geneva, Switzerland.: World Helath Organization; 2001.Search in Google Scholar

3. Ketter TA. Handbook of diagnosis and treatment of bipolar disorder. Washington, DC: American Psychiatric Publishing, Inc.; 2010.Search in Google Scholar

4. Ketter TA, Citrome L, Wang PW, Culver JL, Srivastava S. Treatments for bipolar disorder: can number needed to treat/harm help inform clinical decisions?. Acta Psychiatr Scand. 2011; 123:175-89.10.1111/j.1600-0447.2010.01645.x21133854Search in Google Scholar

5. Frye MA, Ketter TA, Leverich GS, Huggins T, Lantz C, Denicoff KD, et al. The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry. 2000; 61:9-15.10.4088/JCP.v61n010410695639Open DOISearch in Google Scholar

6. Goldberg JF, Brooks JO, 3rd, Kurita K, Hoblyn JC, Ghaemi SN, Perlis RH, et al. Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD. J Clin Psychiatry. 2009; 70:155-62.10.4088/JCP.08m04301Open DOISearch in Google Scholar

7. Young AH, Oren DA, Lowy A, McQuade RD, Marcus RN, Carson WH, et al. Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study. Br J Psychiatry. 2009; 194:40-8.10.1192/bjp.bp.108.04996519118324Search in Google Scholar

8. Keck PE, Orsulak PJ, Cutler AJ, Sanchez R, Torbeyns A, Marcus RN, et al. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study. J Affect Disord. 2009; 112:36-49.10.1016/j.jad.2008.05.01418835043Open DOISearch in Google Scholar

9. Keck PE, Jr., Marcus R, Tourkodimitris S, Ali M, Liebeskind A, Saha A, et al. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry. 2003; 160:1651-8.10.1176/appi.ajp.160.9.165112944341Search in Google Scholar

10. Vieta E, T’Joen C, McQuade RD, Carson WH, Jr, Marcus RN, Sanchez R, et al. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/ lithium monotherapy: a placebo-controlled study. Am J Psychiatry. 2008; 165:1316-25.10.1176/appi.ajp.2008.0710156018381903Search in Google Scholar

11. Keck PE, Calabrese JR, McQuade RD, Carson WH, Carlson BX, Rollin LM, et al. A randomized, doubleblind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. J Clin Psychiatry. 2006; 67:626-37.10.4088/JCP.v67n0414Open DOISearch in Google Scholar

12. Keck PE, Jr, Calabrese JR, McIntyre RS, McQuade RD, Carson WH, Eudicone JM, et al. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study vs. placebo. J Clin Psychiatry. 2007; 68:1480-91.10.4088/JCP.v68n1003Open DOISearch in Google Scholar

13. Marcus R, Khan A, Rollin L, Morris B, Timko K, Carson W, et al. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study. Bipolar Disord. 2011; 13:133-44.10.1111/j.1399-5618.2011.00898.xOpen DOISearch in Google Scholar

14. Thase ME, Jonas A, Khan A, Bowden CL, Wu X, McQuade RD, et al. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies. J Clin Psychopharmacol. 2008; 28:13-20.10.1097/jcp.0b013e3181618eb4Open DOISearch in Google Scholar

15. Quante A, Zeugmann S, Luborzewski A, Schommer N, Langosch J, Born C, et al. Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study. Hum Psychopharmacol. 2010; 25:126-32.10.1002/hup.1096Open DOISearch in Google Scholar

16. Woo YS, Bahk W-M, Chung MY, Kim D-H, Yoon B-H, Lee JH, et al. Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, doubleblind maintenance trial. Hum Psychopharmacol. 2011; 26:543-53.10.1002/hup.1240Open DOISearch in Google Scholar

17. Ketter TA, Wang PW, Chandler RA, Culver JL, Alarcon AM. Adjunctive aripiprazole in treatmentresistant bipolar depression. Ann Clin Psychiatry. 2006; 18:169-72.10.1080/10401230600801176Open DOISearch in Google Scholar

18. Sachs GS, Guille C, McMurrich SL. A clinical monitoring form for mood disorders. Bipolar Disord. 2002; 4:323-7.10.1034/j.1399-5618.2002.01195.xOpen DOISearch in Google Scholar

19. Sachs GS, Thase ME, Otto MW, Bauer M, Miklowitz D, Wisniewski SR, et al. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry. 2003; 53:1028-42.10.1016/S0006-3223(03)00165-3Open DOISearch in Google Scholar

20. Dennehy EB, Bauer MS, Perlis RH, Kogan JN, Sachs GS. Concordance with treatment guidelines for bipolar disorder: data from the systematic treatment enhancement program for bipolar disorder. Psychopharmacol Bull. 2007; 40:72-84.Search in Google Scholar

21. American Psychiatric Association, editor. Diagnostic and statistical manual of mental disorders. Text reision (DSM-IV-TR). 4th ed. Washington: American Psychiatric Association; 2000.Search in Google Scholar

22. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990; 264:2511-8.10.1001/jama.1990.03450190043026Search in Google Scholar

23. Grant BF, Stinson FS, Hasin DS, Dawson DA, Chou SP, Ruan WJ, et al. Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2005; 66:1205-15.10.4088/JCP.v66n1001Open DOISearch in Google Scholar